🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "targeted action to address household expense issues" in the forthcoming financial statement.

Speaking to the BBC, she stated that lowering inflation is a collective duty of both the government and the central bank.

The United Kingdom's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.

Potential Energy Cost Measures

Reports indicate the government could take action to reduce utility costs, such as by slashing the current 5% level of VAT charged on energy.

Another approach is to lower some of the government charges presently added to bills.

Budgetary Limitations and Expert Predictions

The administration will obtain the latest report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for these measures.

The view from the majority of analysts is that the Chancellor will have to declare higher taxes or expenditure reductions in order to meet her voluntary fiscal targets.

Previously on the same day, analysis showed there was a £22 billion deficit for the Treasury chief to resolve, which is at the lower end of expectations.

"It is a shared task between the central bank and the government to further reduce some of the sources of inflation," Reeves informed reporters in the US capital, at the conferences of the IMF and World Bank.

Tax Pledges and International Concerns

While much of the attention has been on expected tax rises, the chancellor said the most recent data from the OBR had not changed her commitment to election pledges not to raise tax levels on income tax, VAT or National Insurance.

She blamed an "unpredictable world" with rising geopolitical and commercial issues for the Budget revenue measures, likely to be directed on those "most able to pay."

Global Economic Tensions

Commenting on worries about the UK's trade ties with the Asian nation she said: "Our national security invariably come first."

Recent statement by China to increase trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to propose an additional 100% import tax on goods from the Asian country, increasing the risk of an all-out trade war between the two global powers.

The US Treasury Secretary called the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on accepting the American proposal to participate in its battle with China, Reeves said she was "deeply worried" by Chinese measures and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "bad for the global economy and creates further challenges."

"I believe there are areas where we must confront China, but there are also important opportunities to sell into China's economy, including banking sector and other areas of the economic system. We've got to get that balance appropriate."

The chancellor also confirmed she was cooperating with international partners "regarding our own critical minerals strategy, so that we are less reliant."

Health Service Drug Pricing and Investment

The Chancellor also admitted that the cost the National Health Service pays for medicines could rise as a result of ongoing talks with the US government and its drugs companies, in return for reduced taxes and funding.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or scrapping investments in the UK, with several blaming the modest returns they are obtaining.

Recently, the Science Minister said the cost the health service pays for medicines would need to increase to stop companies and drug research funding leaving the UK.

The Chancellor informed the BBC: "It has been observed as a result of the payment system, that drug testing, new drugs have not been offered in the UK in the manner that they are in other European countries."

"The objective is to make sure that individuals receiving treatment from the NHS are can obtain the top life-saving drugs in the globe. And so we are examining this situation, and... seeking to attract more capital into Britain."